BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12883703)

  • 1. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
    Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation.
    Ito Y; Yoshida H; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(1B):569-76. PubMed ID: 12680148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.
    Ito Y; Arai K; Nozawa R; Yoshida H; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Kuma K; Miyauchi A
    Anticancer Res; 2007; 27(4C):2679-83. PubMed ID: 17695432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma.
    Haghpanah V; Shooshtarizadeh P; Heshmat R; Larijani B; Tavangar SM
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):422-5. PubMed ID: 17122639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma.
    Ito Y; Arai K; Ryushi ; Nozawa ; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
    Pathol Res Pract; 2005; 201(8-9):551-6. PubMed ID: 16259107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of S100A2 and S100A6 in thyroid carcinomas.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Histopathology; 2005 May; 46(5):569-75. PubMed ID: 15842639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Poorly differentiated carcinoma of the thyroid--immunohistochemical evaluation of p53 and p27 protein expression].
    Wierzchowski W; Szybiński P; Nowak W; Nowak K; Szybiński Z; Buziak-Bereza M; Stachura J
    Wiad Lek; 2001; 54 Suppl 1():79-87. PubMed ID: 12182066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma.
    Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
    Pathol Res Pract; 2003; 199(2):79-83. PubMed ID: 12747469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.
    Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
    Int J Mol Med; 2002 Apr; 9(4):373-6. PubMed ID: 11891530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT).
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1B):509-14. PubMed ID: 15816620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.
    Albores-Saavedra J; Hernandez M; Sanchez-Sosa S; Simpson K; Angeles A; Henson DE
    Am J Surg Pathol; 2007 May; 31(5):729-36. PubMed ID: 17460457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma.
    Ito Y; Arai K; Nozawa R; Yoshida H; Hirokawa M; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
    Anticancer Res; 2009 Oct; 29(10):4157-61. PubMed ID: 19846966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCT4 expression on a case of poorly differentiated (insular) carcinoma of the thyroid gland and minireview.
    Ruangpratheep C; Lohachittranond C; Poonpracha T; Punyarit P
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S281-9. PubMed ID: 16858970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of protein p53: the marker of low neoplastic cell differentiation in thyroid carcinoma].
    Szybiński P; Nowak W; Stachura J; Nowak K; Przybylik-Mazurek E; Buziak-Bereza M
    Wiad Lek; 2001; 54 Suppl 1():88-94. PubMed ID: 12182067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.